nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydromorphone—PTGS1—breast cancer	0.163	0.442	CbGaD
Hydromorphone—CYP2D6—breast cancer	0.111	0.301	CbGaD
Hydromorphone—CYP3A4—breast cancer	0.0949	0.258	CbGaD
Hydromorphone—UGT1A9—Irinotecan—breast cancer	0.0462	0.128	CbGbCtD
Hydromorphone—CYP2C9—Anastrozole—breast cancer	0.0301	0.0834	CbGbCtD
Hydromorphone—CYP3A4—Exemestane—breast cancer	0.0231	0.064	CbGbCtD
Hydromorphone—CYP2C9—Idarubicin—breast cancer	0.0228	0.0632	CbGbCtD
Hydromorphone—CYP2D6—Idarubicin—breast cancer	0.0209	0.0578	CbGbCtD
Hydromorphone—CYP3A4—Letrozole—breast cancer	0.0196	0.0544	CbGbCtD
Hydromorphone—CYP3A4—Anastrozole—breast cancer	0.0175	0.0485	CbGbCtD
Hydromorphone—CYP3A4—Toremifene—breast cancer	0.016	0.0443	CbGbCtD
Hydromorphone—CYP3A4—Fulvestrant—breast cancer	0.0149	0.0412	CbGbCtD
Hydromorphone—CYP3A4—Thiotepa—breast cancer	0.0133	0.0367	CbGbCtD
Hydromorphone—CYP2C9—Capecitabine—breast cancer	0.0125	0.0346	CbGbCtD
Hydromorphone—CYP3A4—Ixabepilone—breast cancer	0.0121	0.0336	CbGbCtD
Hydromorphone—CYP3A4—Lapatinib—breast cancer	0.0117	0.0323	CbGbCtD
Hydromorphone—CYP2D6—Vinorelbine—breast cancer	0.0102	0.0282	CbGbCtD
Hydromorphone—CYP2C9—Tamoxifen—breast cancer	0.0101	0.0278	CbGbCtD
Hydromorphone—CYP2D6—Tamoxifen—breast cancer	0.0092	0.0255	CbGbCtD
Hydromorphone—CYP3A4—Raloxifene—breast cancer	0.00886	0.0245	CbGbCtD
Hydromorphone—CYP2C9—Paclitaxel—breast cancer	0.00783	0.0217	CbGbCtD
Hydromorphone—CYP2C9—Fluorouracil—breast cancer	0.00741	0.0205	CbGbCtD
Hydromorphone—CYP3A4—Vinorelbine—breast cancer	0.00648	0.0179	CbGbCtD
Hydromorphone—CYP2D6—Vinblastine—breast cancer	0.00628	0.0174	CbGbCtD
Hydromorphone—CYP3A4—Tamoxifen—breast cancer	0.00585	0.0162	CbGbCtD
Hydromorphone—CYP3A4—Mitoxantrone—breast cancer	0.00571	0.0158	CbGbCtD
Hydromorphone—CYP3A4—Paclitaxel—breast cancer	0.00455	0.0126	CbGbCtD
Hydromorphone—CYP3A4—Irinotecan—breast cancer	0.00449	0.0124	CbGbCtD
Hydromorphone—CYP3A4—Vinblastine—breast cancer	0.00399	0.0111	CbGbCtD
Hydromorphone—CYP2D6—Doxorubicin—breast cancer	0.00386	0.0107	CbGbCtD
Hydromorphone—CYP3A4—Docetaxel—breast cancer	0.00329	0.00911	CbGbCtD
Hydromorphone—CYP3A4—Doxorubicin—breast cancer	0.00245	0.00679	CbGbCtD
Hydromorphone—Methylnaltrexone—CYP2D6—breast cancer	0.000219	0.0739	CrCbGaD
Hydromorphone—Naloxone—ESR1—breast cancer	0.000201	0.0675	CrCbGaD
Hydromorphone—Dihydrocodeine—CYP2D6—breast cancer	0.000187	0.0628	CrCbGaD
Hydromorphone—Oxymorphone—CYP2D6—breast cancer	0.000164	0.0551	CrCbGaD
Hydromorphone—Dihydrocodeine—CYP3A4—breast cancer	0.00016	0.0539	CrCbGaD
Hydromorphone—Ethylmorphine—CYP2D6—breast cancer	0.000156	0.0526	CrCbGaD
Hydromorphone—Hydrocodone—CYP2D6—breast cancer	0.000143	0.0481	CrCbGaD
Hydromorphone—Oxymorphone—CYP3A4—breast cancer	0.00014	0.0472	CrCbGaD
Hydromorphone—Ethylmorphine—CYP3A4—breast cancer	0.000134	0.0451	CrCbGaD
Hydromorphone—Oxycodone—CYP2D6—breast cancer	0.00013	0.0439	CrCbGaD
Hydromorphone—Codeine—CYP2D6—breast cancer	0.000124	0.0419	CrCbGaD
Hydromorphone—Hydrocodone—CYP3A4—breast cancer	0.000123	0.0413	CrCbGaD
Hydromorphone—Naltrexone—ABCB1—breast cancer	0.000117	0.0393	CrCbGaD
Hydromorphone—Oxycodone—CYP3A4—breast cancer	0.000112	0.0377	CrCbGaD
Hydromorphone—Codeine—CYP3A4—breast cancer	0.000107	0.0359	CrCbGaD
Hydromorphone—Naloxone—CYP3A4—breast cancer	0.000102	0.0345	CrCbGaD
Hydromorphone—Morphine—CYP2D6—breast cancer	0.000101	0.0339	CrCbGaD
Hydromorphone—Naloxone—ALB—breast cancer	8.93e-05	0.0301	CrCbGaD
Hydromorphone—Morphine—CYP3A4—breast cancer	8.64e-05	0.0291	CrCbGaD
Hydromorphone—Naloxone—ABCB1—breast cancer	8.52e-05	0.0287	CrCbGaD
Hydromorphone—Dextromethorphan—CYP2D6—breast cancer	8.46e-05	0.0285	CrCbGaD
Hydromorphone—Dextromethorphan—CYP3A4—breast cancer	7.25e-05	0.0244	CrCbGaD
Hydromorphone—Morphine—ABCB1—breast cancer	7.19e-05	0.0242	CrCbGaD
Hydromorphone—Dextromethorphan—ABCB1—breast cancer	6.04e-05	0.0203	CrCbGaD
Hydromorphone—Decreased appetite—Docetaxel—breast cancer	2.84e-05	0.000152	CcSEcCtD
Hydromorphone—Hypersensitivity—Paclitaxel—breast cancer	2.84e-05	0.000152	CcSEcCtD
Hydromorphone—Headache—Fluorouracil—breast cancer	2.83e-05	0.000152	CcSEcCtD
Hydromorphone—Urinary tract disorder—Doxorubicin—breast cancer	2.83e-05	0.000152	CcSEcCtD
Hydromorphone—Oedema peripheral—Doxorubicin—breast cancer	2.82e-05	0.000152	CcSEcCtD
Hydromorphone—Dysgeusia—Methotrexate—breast cancer	2.82e-05	0.000151	CcSEcCtD
Hydromorphone—Gastrointestinal disorder—Docetaxel—breast cancer	2.82e-05	0.000151	CcSEcCtD
Hydromorphone—Connective tissue disorder—Doxorubicin—breast cancer	2.82e-05	0.000151	CcSEcCtD
Hydromorphone—Dyspnoea—Capecitabine—breast cancer	2.82e-05	0.000151	CcSEcCtD
Hydromorphone—Fatigue—Docetaxel—breast cancer	2.81e-05	0.000151	CcSEcCtD
Hydromorphone—Angiopathy—Epirubicin—breast cancer	2.81e-05	0.000151	CcSEcCtD
Hydromorphone—Urethral disorder—Doxorubicin—breast cancer	2.81e-05	0.000151	CcSEcCtD
Hydromorphone—Nausea—Irinotecan—breast cancer	2.8e-05	0.000151	CcSEcCtD
Hydromorphone—Nausea—Mitoxantrone—breast cancer	2.8e-05	0.000151	CcSEcCtD
Hydromorphone—Immune system disorder—Epirubicin—breast cancer	2.8e-05	0.00015	CcSEcCtD
Hydromorphone—Mediastinal disorder—Epirubicin—breast cancer	2.79e-05	0.00015	CcSEcCtD
Hydromorphone—Pain—Docetaxel—breast cancer	2.79e-05	0.00015	CcSEcCtD
Hydromorphone—Constipation—Docetaxel—breast cancer	2.79e-05	0.00015	CcSEcCtD
Hydromorphone—Back pain—Methotrexate—breast cancer	2.79e-05	0.00015	CcSEcCtD
Hydromorphone—Dyspepsia—Capecitabine—breast cancer	2.78e-05	0.000149	CcSEcCtD
Hydromorphone—Chills—Epirubicin—breast cancer	2.78e-05	0.000149	CcSEcCtD
Hydromorphone—Arrhythmia—Epirubicin—breast cancer	2.77e-05	0.000149	CcSEcCtD
Hydromorphone—Visual impairment—Doxorubicin—breast cancer	2.76e-05	0.000148	CcSEcCtD
Hydromorphone—Asthenia—Paclitaxel—breast cancer	2.76e-05	0.000148	CcSEcCtD
Hydromorphone—Decreased appetite—Capecitabine—breast cancer	2.75e-05	0.000147	CcSEcCtD
Hydromorphone—Nausea—Gemcitabine—breast cancer	2.73e-05	0.000147	CcSEcCtD
Hydromorphone—Gastrointestinal disorder—Capecitabine—breast cancer	2.73e-05	0.000146	CcSEcCtD
Hydromorphone—Fatigue—Capecitabine—breast cancer	2.72e-05	0.000146	CcSEcCtD
Hydromorphone—Pruritus—Paclitaxel—breast cancer	2.72e-05	0.000146	CcSEcCtD
Hydromorphone—Vision blurred—Methotrexate—breast cancer	2.72e-05	0.000146	CcSEcCtD
Hydromorphone—Mental disorder—Epirubicin—breast cancer	2.71e-05	0.000146	CcSEcCtD
Hydromorphone—Constipation—Capecitabine—breast cancer	2.7e-05	0.000145	CcSEcCtD
Hydromorphone—Pain—Capecitabine—breast cancer	2.7e-05	0.000145	CcSEcCtD
Hydromorphone—Erythema—Epirubicin—breast cancer	2.7e-05	0.000145	CcSEcCtD
Hydromorphone—Malnutrition—Epirubicin—breast cancer	2.7e-05	0.000145	CcSEcCtD
Hydromorphone—Feeling abnormal—Docetaxel—breast cancer	2.69e-05	0.000144	CcSEcCtD
Hydromorphone—Nausea—Fluorouracil—breast cancer	2.69e-05	0.000144	CcSEcCtD
Hydromorphone—Eye disorder—Doxorubicin—breast cancer	2.68e-05	0.000144	CcSEcCtD
Hydromorphone—Ill-defined disorder—Methotrexate—breast cancer	2.67e-05	0.000144	CcSEcCtD
Hydromorphone—Tinnitus—Doxorubicin—breast cancer	2.67e-05	0.000143	CcSEcCtD
Hydromorphone—Gastrointestinal pain—Docetaxel—breast cancer	2.67e-05	0.000143	CcSEcCtD
Hydromorphone—Cardiac disorder—Doxorubicin—breast cancer	2.66e-05	0.000143	CcSEcCtD
Hydromorphone—Flushing—Doxorubicin—breast cancer	2.66e-05	0.000143	CcSEcCtD
Hydromorphone—Flatulence—Epirubicin—breast cancer	2.66e-05	0.000143	CcSEcCtD
Hydromorphone—Tension—Epirubicin—breast cancer	2.65e-05	0.000142	CcSEcCtD
Hydromorphone—Dysgeusia—Epirubicin—breast cancer	2.64e-05	0.000142	CcSEcCtD
Hydromorphone—Diarrhoea—Paclitaxel—breast cancer	2.63e-05	0.000141	CcSEcCtD
Hydromorphone—Nervousness—Epirubicin—breast cancer	2.62e-05	0.000141	CcSEcCtD
Hydromorphone—Back pain—Epirubicin—breast cancer	2.61e-05	0.00014	CcSEcCtD
Hydromorphone—Feeling abnormal—Capecitabine—breast cancer	2.6e-05	0.00014	CcSEcCtD
Hydromorphone—Angiopathy—Doxorubicin—breast cancer	2.6e-05	0.00014	CcSEcCtD
Hydromorphone—Malaise—Methotrexate—breast cancer	2.6e-05	0.00014	CcSEcCtD
Hydromorphone—Muscle spasms—Epirubicin—breast cancer	2.59e-05	0.000139	CcSEcCtD
Hydromorphone—Immune system disorder—Doxorubicin—breast cancer	2.59e-05	0.000139	CcSEcCtD
Hydromorphone—Vertigo—Methotrexate—breast cancer	2.59e-05	0.000139	CcSEcCtD
Hydromorphone—Gastrointestinal pain—Capecitabine—breast cancer	2.58e-05	0.000139	CcSEcCtD
Hydromorphone—Mediastinal disorder—Doxorubicin—breast cancer	2.58e-05	0.000139	CcSEcCtD
Hydromorphone—Abdominal pain—Docetaxel—breast cancer	2.58e-05	0.000138	CcSEcCtD
Hydromorphone—Body temperature increased—Docetaxel—breast cancer	2.58e-05	0.000138	CcSEcCtD
Hydromorphone—Leukopenia—Methotrexate—breast cancer	2.58e-05	0.000138	CcSEcCtD
Hydromorphone—Chills—Doxorubicin—breast cancer	2.57e-05	0.000138	CcSEcCtD
Hydromorphone—Arrhythmia—Doxorubicin—breast cancer	2.56e-05	0.000137	CcSEcCtD
Hydromorphone—Dizziness—Paclitaxel—breast cancer	2.55e-05	0.000137	CcSEcCtD
Hydromorphone—Vision blurred—Epirubicin—breast cancer	2.54e-05	0.000136	CcSEcCtD
Hydromorphone—Cough—Methotrexate—breast cancer	2.51e-05	0.000135	CcSEcCtD
Hydromorphone—Mental disorder—Doxorubicin—breast cancer	2.51e-05	0.000135	CcSEcCtD
Hydromorphone—Urticaria—Capecitabine—breast cancer	2.51e-05	0.000135	CcSEcCtD
Hydromorphone—Ill-defined disorder—Epirubicin—breast cancer	2.5e-05	0.000134	CcSEcCtD
Hydromorphone—Abdominal pain—Capecitabine—breast cancer	2.5e-05	0.000134	CcSEcCtD
Hydromorphone—Body temperature increased—Capecitabine—breast cancer	2.5e-05	0.000134	CcSEcCtD
Hydromorphone—Convulsion—Methotrexate—breast cancer	2.5e-05	0.000134	CcSEcCtD
Hydromorphone—Erythema—Doxorubicin—breast cancer	2.5e-05	0.000134	CcSEcCtD
Hydromorphone—Malnutrition—Doxorubicin—breast cancer	2.5e-05	0.000134	CcSEcCtD
Hydromorphone—Agitation—Epirubicin—breast cancer	2.48e-05	0.000133	CcSEcCtD
Hydromorphone—Flatulence—Doxorubicin—breast cancer	2.46e-05	0.000132	CcSEcCtD
Hydromorphone—Arthralgia—Methotrexate—breast cancer	2.45e-05	0.000132	CcSEcCtD
Hydromorphone—Chest pain—Methotrexate—breast cancer	2.45e-05	0.000132	CcSEcCtD
Hydromorphone—Myalgia—Methotrexate—breast cancer	2.45e-05	0.000132	CcSEcCtD
Hydromorphone—Tension—Doxorubicin—breast cancer	2.45e-05	0.000131	CcSEcCtD
Hydromorphone—Vomiting—Paclitaxel—breast cancer	2.45e-05	0.000131	CcSEcCtD
Hydromorphone—Dysgeusia—Doxorubicin—breast cancer	2.44e-05	0.000131	CcSEcCtD
Hydromorphone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	2.44e-05	0.000131	CcSEcCtD
Hydromorphone—Malaise—Epirubicin—breast cancer	2.43e-05	0.000131	CcSEcCtD
Hydromorphone—Rash—Paclitaxel—breast cancer	2.43e-05	0.00013	CcSEcCtD
Hydromorphone—Dermatitis—Paclitaxel—breast cancer	2.42e-05	0.00013	CcSEcCtD
Hydromorphone—Discomfort—Methotrexate—breast cancer	2.42e-05	0.00013	CcSEcCtD
Hydromorphone—Nervousness—Doxorubicin—breast cancer	2.42e-05	0.00013	CcSEcCtD
Hydromorphone—Vertigo—Epirubicin—breast cancer	2.42e-05	0.00013	CcSEcCtD
Hydromorphone—Syncope—Epirubicin—breast cancer	2.42e-05	0.00013	CcSEcCtD
Hydromorphone—Leukopenia—Epirubicin—breast cancer	2.41e-05	0.00013	CcSEcCtD
Hydromorphone—Back pain—Doxorubicin—breast cancer	2.41e-05	0.00013	CcSEcCtD
Hydromorphone—Headache—Paclitaxel—breast cancer	2.41e-05	0.000129	CcSEcCtD
Hydromorphone—Hypersensitivity—Docetaxel—breast cancer	2.4e-05	0.000129	CcSEcCtD
Hydromorphone—Muscle spasms—Doxorubicin—breast cancer	2.4e-05	0.000129	CcSEcCtD
Hydromorphone—Palpitations—Epirubicin—breast cancer	2.38e-05	0.000128	CcSEcCtD
Hydromorphone—Confusional state—Methotrexate—breast cancer	2.37e-05	0.000127	CcSEcCtD
Hydromorphone—Loss of consciousness—Epirubicin—breast cancer	2.37e-05	0.000127	CcSEcCtD
Hydromorphone—Cough—Epirubicin—breast cancer	2.35e-05	0.000126	CcSEcCtD
Hydromorphone—Anaphylactic shock—Methotrexate—breast cancer	2.35e-05	0.000126	CcSEcCtD
Hydromorphone—Vision blurred—Doxorubicin—breast cancer	2.35e-05	0.000126	CcSEcCtD
Hydromorphone—Asthenia—Docetaxel—breast cancer	2.34e-05	0.000126	CcSEcCtD
Hydromorphone—Convulsion—Epirubicin—breast cancer	2.34e-05	0.000125	CcSEcCtD
Hydromorphone—Infection—Methotrexate—breast cancer	2.34e-05	0.000125	CcSEcCtD
Hydromorphone—Hypertension—Epirubicin—breast cancer	2.33e-05	0.000125	CcSEcCtD
Hydromorphone—Hypersensitivity—Capecitabine—breast cancer	2.33e-05	0.000125	CcSEcCtD
Hydromorphone—Ill-defined disorder—Doxorubicin—breast cancer	2.31e-05	0.000124	CcSEcCtD
Hydromorphone—Pruritus—Docetaxel—breast cancer	2.31e-05	0.000124	CcSEcCtD
Hydromorphone—Nervous system disorder—Methotrexate—breast cancer	2.31e-05	0.000124	CcSEcCtD
Hydromorphone—Chest pain—Epirubicin—breast cancer	2.3e-05	0.000123	CcSEcCtD
Hydromorphone—Arthralgia—Epirubicin—breast cancer	2.3e-05	0.000123	CcSEcCtD
Hydromorphone—Myalgia—Epirubicin—breast cancer	2.3e-05	0.000123	CcSEcCtD
Hydromorphone—Agitation—Doxorubicin—breast cancer	2.29e-05	0.000123	CcSEcCtD
Hydromorphone—Anxiety—Epirubicin—breast cancer	2.29e-05	0.000123	CcSEcCtD
Hydromorphone—Nausea—Paclitaxel—breast cancer	2.29e-05	0.000123	CcSEcCtD
Hydromorphone—Skin disorder—Methotrexate—breast cancer	2.28e-05	0.000123	CcSEcCtD
Hydromorphone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	2.28e-05	0.000122	CcSEcCtD
Hydromorphone—Hyperhidrosis—Methotrexate—breast cancer	2.27e-05	0.000122	CcSEcCtD
Hydromorphone—Discomfort—Epirubicin—breast cancer	2.27e-05	0.000122	CcSEcCtD
Hydromorphone—Asthenia—Capecitabine—breast cancer	2.27e-05	0.000122	CcSEcCtD
Hydromorphone—Malaise—Doxorubicin—breast cancer	2.25e-05	0.000121	CcSEcCtD
Hydromorphone—Dry mouth—Epirubicin—breast cancer	2.25e-05	0.000121	CcSEcCtD
Hydromorphone—Vertigo—Doxorubicin—breast cancer	2.24e-05	0.00012	CcSEcCtD
Hydromorphone—Anorexia—Methotrexate—breast cancer	2.24e-05	0.00012	CcSEcCtD
Hydromorphone—Syncope—Doxorubicin—breast cancer	2.24e-05	0.00012	CcSEcCtD
Hydromorphone—Pruritus—Capecitabine—breast cancer	2.23e-05	0.00012	CcSEcCtD
Hydromorphone—Leukopenia—Doxorubicin—breast cancer	2.23e-05	0.00012	CcSEcCtD
Hydromorphone—Diarrhoea—Docetaxel—breast cancer	2.23e-05	0.00012	CcSEcCtD
Hydromorphone—Confusional state—Epirubicin—breast cancer	2.22e-05	0.000119	CcSEcCtD
Hydromorphone—Palpitations—Doxorubicin—breast cancer	2.2e-05	0.000118	CcSEcCtD
Hydromorphone—Anaphylactic shock—Epirubicin—breast cancer	2.2e-05	0.000118	CcSEcCtD
Hydromorphone—Hypotension—Methotrexate—breast cancer	2.2e-05	0.000118	CcSEcCtD
Hydromorphone—Loss of consciousness—Doxorubicin—breast cancer	2.19e-05	0.000118	CcSEcCtD
Hydromorphone—Infection—Epirubicin—breast cancer	2.19e-05	0.000117	CcSEcCtD
Hydromorphone—Cough—Doxorubicin—breast cancer	2.18e-05	0.000117	CcSEcCtD
Hydromorphone—Shock—Epirubicin—breast cancer	2.17e-05	0.000116	CcSEcCtD
Hydromorphone—Convulsion—Doxorubicin—breast cancer	2.16e-05	0.000116	CcSEcCtD
Hydromorphone—Diarrhoea—Capecitabine—breast cancer	2.16e-05	0.000116	CcSEcCtD
Hydromorphone—Nervous system disorder—Epirubicin—breast cancer	2.16e-05	0.000116	CcSEcCtD
Hydromorphone—Dizziness—Docetaxel—breast cancer	2.16e-05	0.000116	CcSEcCtD
Hydromorphone—Hypertension—Doxorubicin—breast cancer	2.15e-05	0.000116	CcSEcCtD
Hydromorphone—Tachycardia—Epirubicin—breast cancer	2.15e-05	0.000115	CcSEcCtD
Hydromorphone—Musculoskeletal discomfort—Methotrexate—breast cancer	2.14e-05	0.000115	CcSEcCtD
Hydromorphone—Skin disorder—Epirubicin—breast cancer	2.14e-05	0.000115	CcSEcCtD
Hydromorphone—Hyperhidrosis—Epirubicin—breast cancer	2.13e-05	0.000114	CcSEcCtD
Hydromorphone—Insomnia—Methotrexate—breast cancer	2.13e-05	0.000114	CcSEcCtD
Hydromorphone—Myalgia—Doxorubicin—breast cancer	2.12e-05	0.000114	CcSEcCtD
Hydromorphone—Arthralgia—Doxorubicin—breast cancer	2.12e-05	0.000114	CcSEcCtD
Hydromorphone—Chest pain—Doxorubicin—breast cancer	2.12e-05	0.000114	CcSEcCtD
Hydromorphone—Anxiety—Doxorubicin—breast cancer	2.12e-05	0.000114	CcSEcCtD
Hydromorphone—Paraesthesia—Methotrexate—breast cancer	2.11e-05	0.000113	CcSEcCtD
Hydromorphone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	2.11e-05	0.000113	CcSEcCtD
Hydromorphone—Discomfort—Doxorubicin—breast cancer	2.1e-05	0.000113	CcSEcCtD
Hydromorphone—Anorexia—Epirubicin—breast cancer	2.1e-05	0.000113	CcSEcCtD
Hydromorphone—Dyspnoea—Methotrexate—breast cancer	2.1e-05	0.000113	CcSEcCtD
Hydromorphone—Somnolence—Methotrexate—breast cancer	2.09e-05	0.000112	CcSEcCtD
Hydromorphone—Dizziness—Capecitabine—breast cancer	2.09e-05	0.000112	CcSEcCtD
Hydromorphone—Dry mouth—Doxorubicin—breast cancer	2.08e-05	0.000112	CcSEcCtD
Hydromorphone—Vomiting—Docetaxel—breast cancer	2.07e-05	0.000111	CcSEcCtD
Hydromorphone—Dyspepsia—Methotrexate—breast cancer	2.07e-05	0.000111	CcSEcCtD
Hydromorphone—Rash—Docetaxel—breast cancer	2.06e-05	0.00011	CcSEcCtD
Hydromorphone—Hypotension—Epirubicin—breast cancer	2.06e-05	0.00011	CcSEcCtD
Hydromorphone—Dermatitis—Docetaxel—breast cancer	2.06e-05	0.00011	CcSEcCtD
Hydromorphone—Confusional state—Doxorubicin—breast cancer	2.05e-05	0.00011	CcSEcCtD
Hydromorphone—Decreased appetite—Methotrexate—breast cancer	2.04e-05	0.00011	CcSEcCtD
Hydromorphone—Headache—Docetaxel—breast cancer	2.04e-05	0.00011	CcSEcCtD
Hydromorphone—Anaphylactic shock—Doxorubicin—breast cancer	2.04e-05	0.000109	CcSEcCtD
Hydromorphone—Gastrointestinal disorder—Methotrexate—breast cancer	2.03e-05	0.000109	CcSEcCtD
Hydromorphone—Fatigue—Methotrexate—breast cancer	2.03e-05	0.000109	CcSEcCtD
Hydromorphone—Infection—Doxorubicin—breast cancer	2.02e-05	0.000109	CcSEcCtD
Hydromorphone—Pain—Methotrexate—breast cancer	2.01e-05	0.000108	CcSEcCtD
Hydromorphone—Vomiting—Capecitabine—breast cancer	2.01e-05	0.000108	CcSEcCtD
Hydromorphone—Musculoskeletal discomfort—Epirubicin—breast cancer	2.01e-05	0.000108	CcSEcCtD
Hydromorphone—Shock—Doxorubicin—breast cancer	2e-05	0.000108	CcSEcCtD
Hydromorphone—Nervous system disorder—Doxorubicin—breast cancer	2e-05	0.000107	CcSEcCtD
Hydromorphone—Rash—Capecitabine—breast cancer	1.99e-05	0.000107	CcSEcCtD
Hydromorphone—Insomnia—Epirubicin—breast cancer	1.99e-05	0.000107	CcSEcCtD
Hydromorphone—Dermatitis—Capecitabine—breast cancer	1.99e-05	0.000107	CcSEcCtD
Hydromorphone—Tachycardia—Doxorubicin—breast cancer	1.99e-05	0.000107	CcSEcCtD
Hydromorphone—Headache—Capecitabine—breast cancer	1.98e-05	0.000106	CcSEcCtD
Hydromorphone—Skin disorder—Doxorubicin—breast cancer	1.98e-05	0.000106	CcSEcCtD
Hydromorphone—Paraesthesia—Epirubicin—breast cancer	1.98e-05	0.000106	CcSEcCtD
Hydromorphone—Hyperhidrosis—Doxorubicin—breast cancer	1.97e-05	0.000106	CcSEcCtD
Hydromorphone—Dyspnoea—Epirubicin—breast cancer	1.96e-05	0.000105	CcSEcCtD
Hydromorphone—Somnolence—Epirubicin—breast cancer	1.96e-05	0.000105	CcSEcCtD
Hydromorphone—Anorexia—Doxorubicin—breast cancer	1.94e-05	0.000104	CcSEcCtD
Hydromorphone—Nausea—Docetaxel—breast cancer	1.94e-05	0.000104	CcSEcCtD
Hydromorphone—Feeling abnormal—Methotrexate—breast cancer	1.94e-05	0.000104	CcSEcCtD
Hydromorphone—Dyspepsia—Epirubicin—breast cancer	1.94e-05	0.000104	CcSEcCtD
Hydromorphone—Gastrointestinal pain—Methotrexate—breast cancer	1.92e-05	0.000103	CcSEcCtD
Hydromorphone—Decreased appetite—Epirubicin—breast cancer	1.91e-05	0.000103	CcSEcCtD
Hydromorphone—Hypotension—Doxorubicin—breast cancer	1.9e-05	0.000102	CcSEcCtD
Hydromorphone—Gastrointestinal disorder—Epirubicin—breast cancer	1.9e-05	0.000102	CcSEcCtD
Hydromorphone—Fatigue—Epirubicin—breast cancer	1.9e-05	0.000102	CcSEcCtD
Hydromorphone—Pain—Epirubicin—breast cancer	1.88e-05	0.000101	CcSEcCtD
Hydromorphone—Constipation—Epirubicin—breast cancer	1.88e-05	0.000101	CcSEcCtD
Hydromorphone—Nausea—Capecitabine—breast cancer	1.88e-05	0.000101	CcSEcCtD
Hydromorphone—Urticaria—Methotrexate—breast cancer	1.87e-05	0.0001	CcSEcCtD
Hydromorphone—Body temperature increased—Methotrexate—breast cancer	1.86e-05	9.98e-05	CcSEcCtD
Hydromorphone—Abdominal pain—Methotrexate—breast cancer	1.86e-05	9.98e-05	CcSEcCtD
Hydromorphone—Musculoskeletal discomfort—Doxorubicin—breast cancer	1.86e-05	9.96e-05	CcSEcCtD
Hydromorphone—Insomnia—Doxorubicin—breast cancer	1.84e-05	9.89e-05	CcSEcCtD
Hydromorphone—Paraesthesia—Doxorubicin—breast cancer	1.83e-05	9.82e-05	CcSEcCtD
Hydromorphone—Dyspnoea—Doxorubicin—breast cancer	1.82e-05	9.75e-05	CcSEcCtD
Hydromorphone—Feeling abnormal—Epirubicin—breast cancer	1.81e-05	9.74e-05	CcSEcCtD
Hydromorphone—Somnolence—Doxorubicin—breast cancer	1.81e-05	9.72e-05	CcSEcCtD
Hydromorphone—Gastrointestinal pain—Epirubicin—breast cancer	1.8e-05	9.66e-05	CcSEcCtD
Hydromorphone—Dyspepsia—Doxorubicin—breast cancer	1.79e-05	9.62e-05	CcSEcCtD
Hydromorphone—Decreased appetite—Doxorubicin—breast cancer	1.77e-05	9.5e-05	CcSEcCtD
Hydromorphone—Gastrointestinal disorder—Doxorubicin—breast cancer	1.76e-05	9.44e-05	CcSEcCtD
Hydromorphone—Fatigue—Doxorubicin—breast cancer	1.76e-05	9.43e-05	CcSEcCtD
Hydromorphone—Urticaria—Epirubicin—breast cancer	1.75e-05	9.39e-05	CcSEcCtD
Hydromorphone—Constipation—Doxorubicin—breast cancer	1.74e-05	9.35e-05	CcSEcCtD
Hydromorphone—Pain—Doxorubicin—breast cancer	1.74e-05	9.35e-05	CcSEcCtD
Hydromorphone—Abdominal pain—Epirubicin—breast cancer	1.74e-05	9.34e-05	CcSEcCtD
Hydromorphone—Body temperature increased—Epirubicin—breast cancer	1.74e-05	9.34e-05	CcSEcCtD
Hydromorphone—Hypersensitivity—Methotrexate—breast cancer	1.73e-05	9.3e-05	CcSEcCtD
Hydromorphone—Asthenia—Methotrexate—breast cancer	1.69e-05	9.06e-05	CcSEcCtD
Hydromorphone—Feeling abnormal—Doxorubicin—breast cancer	1.68e-05	9.01e-05	CcSEcCtD
Hydromorphone—Gastrointestinal pain—Doxorubicin—breast cancer	1.67e-05	8.94e-05	CcSEcCtD
Hydromorphone—Pruritus—Methotrexate—breast cancer	1.66e-05	8.93e-05	CcSEcCtD
Hydromorphone—Hypersensitivity—Epirubicin—breast cancer	1.62e-05	8.7e-05	CcSEcCtD
Hydromorphone—Urticaria—Doxorubicin—breast cancer	1.62e-05	8.68e-05	CcSEcCtD
Hydromorphone—Abdominal pain—Doxorubicin—breast cancer	1.61e-05	8.64e-05	CcSEcCtD
Hydromorphone—Body temperature increased—Doxorubicin—breast cancer	1.61e-05	8.64e-05	CcSEcCtD
Hydromorphone—Diarrhoea—Methotrexate—breast cancer	1.61e-05	8.64e-05	CcSEcCtD
Hydromorphone—Asthenia—Epirubicin—breast cancer	1.58e-05	8.48e-05	CcSEcCtD
Hydromorphone—Pruritus—Epirubicin—breast cancer	1.56e-05	8.36e-05	CcSEcCtD
Hydromorphone—Dizziness—Methotrexate—breast cancer	1.56e-05	8.35e-05	CcSEcCtD
Hydromorphone—Diarrhoea—Epirubicin—breast cancer	1.51e-05	8.08e-05	CcSEcCtD
Hydromorphone—Hypersensitivity—Doxorubicin—breast cancer	1.5e-05	8.05e-05	CcSEcCtD
Hydromorphone—Vomiting—Methotrexate—breast cancer	1.5e-05	8.03e-05	CcSEcCtD
Hydromorphone—Rash—Methotrexate—breast cancer	1.48e-05	7.96e-05	CcSEcCtD
Hydromorphone—Dermatitis—Methotrexate—breast cancer	1.48e-05	7.95e-05	CcSEcCtD
Hydromorphone—Headache—Methotrexate—breast cancer	1.47e-05	7.91e-05	CcSEcCtD
Hydromorphone—Asthenia—Doxorubicin—breast cancer	1.46e-05	7.84e-05	CcSEcCtD
Hydromorphone—Dizziness—Epirubicin—breast cancer	1.46e-05	7.81e-05	CcSEcCtD
Hydromorphone—Pruritus—Doxorubicin—breast cancer	1.44e-05	7.73e-05	CcSEcCtD
Hydromorphone—Vomiting—Epirubicin—breast cancer	1.4e-05	7.51e-05	CcSEcCtD
Hydromorphone—Nausea—Methotrexate—breast cancer	1.4e-05	7.5e-05	CcSEcCtD
Hydromorphone—Diarrhoea—Doxorubicin—breast cancer	1.39e-05	7.48e-05	CcSEcCtD
Hydromorphone—Rash—Epirubicin—breast cancer	1.39e-05	7.45e-05	CcSEcCtD
Hydromorphone—Dermatitis—Epirubicin—breast cancer	1.39e-05	7.44e-05	CcSEcCtD
Hydromorphone—Headache—Epirubicin—breast cancer	1.38e-05	7.4e-05	CcSEcCtD
Hydromorphone—Dizziness—Doxorubicin—breast cancer	1.35e-05	7.23e-05	CcSEcCtD
Hydromorphone—Nausea—Epirubicin—breast cancer	1.31e-05	7.02e-05	CcSEcCtD
Hydromorphone—Vomiting—Doxorubicin—breast cancer	1.29e-05	6.95e-05	CcSEcCtD
Hydromorphone—Rash—Doxorubicin—breast cancer	1.28e-05	6.89e-05	CcSEcCtD
Hydromorphone—Dermatitis—Doxorubicin—breast cancer	1.28e-05	6.89e-05	CcSEcCtD
Hydromorphone—Headache—Doxorubicin—breast cancer	1.28e-05	6.85e-05	CcSEcCtD
Hydromorphone—Nausea—Doxorubicin—breast cancer	1.21e-05	6.49e-05	CcSEcCtD
Hydromorphone—CYP3A4—Metabolism—GPX2—breast cancer	4.35e-06	5.35e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—GSTA2—breast cancer	4.35e-06	5.35e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling by GPCR—HRAS—breast cancer	4.34e-06	5.35e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—NOS3—breast cancer	4.32e-06	5.32e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—FASN—breast cancer	4.3e-06	5.3e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—SULT1A1—breast cancer	4.3e-06	5.29e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—GPX4—breast cancer	4.3e-06	5.29e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—BCHE—breast cancer	4.29e-06	5.27e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—CDKN1B—breast cancer	4.27e-06	5.25e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—FASN—breast cancer	4.27e-06	5.25e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—BCHE—breast cancer	4.25e-06	5.23e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—SLC5A5—breast cancer	4.23e-06	5.21e-05	CbGpPWpGaD
Hydromorphone—OPRD1—GPCR downstream signaling—AKT1—breast cancer	4.22e-06	5.2e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—MAPK3—breast cancer	4.22e-06	5.19e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—SLC5A5—breast cancer	4.2e-06	5.16e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—GSTA1—breast cancer	4.2e-06	5.16e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—IDH1—breast cancer	4.2e-06	5.16e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—CASP3—breast cancer	4.19e-06	5.15e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—IL2—breast cancer	4.18e-06	5.14e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling by GPCR—IL6—breast cancer	4.16e-06	5.12e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—NAT2—breast cancer	4.15e-06	5.1e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—BRAF—breast cancer	4.14e-06	5.09e-05	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—PIK3CB—breast cancer	4.12e-06	5.08e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling by GPCR—PIK3CA—breast cancer	4.12e-06	5.07e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—MDM2—breast cancer	4.1e-06	5.05e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—SLC2A1—breast cancer	4.09e-06	5.03e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—NQO1—breast cancer	4.09e-06	5.03e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—RAF1—breast cancer	4.09e-06	5.03e-05	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—PTGS2—breast cancer	4.09e-06	5.03e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—CCND1—breast cancer	4.07e-06	5.01e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—RELA—breast cancer	4.07e-06	5.01e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—JUN—breast cancer	4.07e-06	5e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—NQO1—breast cancer	4.05e-06	4.99e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—SLC2A1—breast cancer	4.05e-06	4.99e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—ERBB2—breast cancer	4.04e-06	4.98e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—CTNNB1—breast cancer	4.03e-06	4.96e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—IGF1—breast cancer	4.03e-06	4.96e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—AKT2—breast cancer	4.03e-06	4.96e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—EGFR—breast cancer	4.01e-06	4.93e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—MTOR—breast cancer	3.99e-06	4.91e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—PIK3CB—breast cancer	3.99e-06	4.91e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—CYP3A4—breast cancer	3.99e-06	4.91e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	3.97e-06	4.88e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—MMP9—breast cancer	3.96e-06	4.87e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—CYP3A4—breast cancer	3.95e-06	4.86e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—CDKN1A—breast cancer	3.94e-06	4.85e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	3.93e-06	4.84e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—PTEN—breast cancer	3.93e-06	4.84e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—CYP1B1—breast cancer	3.92e-06	4.82e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—CYP1B1—breast cancer	3.89e-06	4.78e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—PIK3CD—breast cancer	3.87e-06	4.76e-05	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—PIK3CD—breast cancer	3.86e-06	4.75e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—MAPK8—breast cancer	3.85e-06	4.73e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—HSP90AA1—breast cancer	3.84e-06	4.73e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling by GPCR—AKT1—breast cancer	3.84e-06	4.72e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—CXCL8—breast cancer	3.83e-06	4.72e-05	CbGpPWpGaD
Hydromorphone—OPRM1—GPCR downstream signaling—PIK3CA—breast cancer	3.83e-06	4.72e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—SERPINE1—breast cancer	3.83e-06	4.71e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—HSP90AA1—breast cancer	3.81e-06	4.69e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling by GPCR—HRAS—breast cancer	3.81e-06	4.69e-05	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—ALB—breast cancer	3.81e-06	4.69e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—KRAS—breast cancer	3.79e-06	4.66e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—CDKN1B—breast cancer	3.74e-06	4.61e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—NCOA1—breast cancer	3.74e-06	4.6e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—NCOA1—breast cancer	3.71e-06	4.56e-05	CbGpPWpGaD
Hydromorphone—OPRK1—GPCR downstream signaling—AKT1—breast cancer	3.7e-06	4.56e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—CYP19A1—breast cancer	3.69e-06	4.53e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—STK11—breast cancer	3.69e-06	4.53e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—CASP3—breast cancer	3.67e-06	4.52e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—IL2—breast cancer	3.66e-06	4.51e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—CYP19A1—breast cancer	3.65e-06	4.5e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—STK11—breast cancer	3.65e-06	4.5e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—NOS3—breast cancer	3.65e-06	4.5e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—SRC—breast cancer	3.65e-06	4.49e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling by GPCR—IL6—breast cancer	3.65e-06	4.49e-05	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—NOS3—breast cancer	3.64e-06	4.48e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—MED12—breast cancer	3.64e-06	4.48e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—DPYD—breast cancer	3.64e-06	4.48e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—ALDOA—breast cancer	3.58e-06	4.41e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—CCND1—breast cancer	3.57e-06	4.4e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—JUN—breast cancer	3.57e-06	4.39e-05	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—PTEN—breast cancer	3.56e-06	4.39e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—VEGFA—breast cancer	3.55e-06	4.37e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—CTNNB1—breast cancer	3.54e-06	4.35e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—STAT3—breast cancer	3.52e-06	4.33e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—PIK3CA—breast cancer	3.48e-06	4.28e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—NCOA3—breast cancer	3.48e-06	4.28e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—MMP9—breast cancer	3.47e-06	4.27e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—MDM2—breast cancer	3.47e-06	4.27e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—CDKN1A—breast cancer	3.46e-06	4.25e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—RAF1—breast cancer	3.45e-06	4.25e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—SLC2A2—breast cancer	3.45e-06	4.25e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—PTEN—breast cancer	3.45e-06	4.24e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—RELA—breast cancer	3.44e-06	4.23e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—breast cancer	3.43e-06	4.22e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—COMT—breast cancer	3.43e-06	4.22e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—ERBB2—breast cancer	3.42e-06	4.21e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—GSTP1—breast cancer	3.41e-06	4.2e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—COMT—breast cancer	3.4e-06	4.18e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—ABCG2—breast cancer	3.38e-06	4.16e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—MTR—breast cancer	3.38e-06	4.16e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—CPT1A—breast cancer	3.38e-06	4.16e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—GSTP1—breast cancer	3.38e-06	4.16e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—MAPK8—breast cancer	3.37e-06	4.15e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—MTOR—breast cancer	3.37e-06	4.15e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—PIK3CB—breast cancer	3.37e-06	4.15e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling by GPCR—AKT1—breast cancer	3.36e-06	4.14e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—HMOX1—breast cancer	3.36e-06	4.14e-05	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—PIK3CB—breast cancer	3.36e-06	4.14e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—MAPK3—breast cancer	3.36e-06	4.13e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—ITPR1—breast cancer	3.36e-06	4.13e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—HMOX1—breast cancer	3.33e-06	4.1e-05	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—PTGS2—breast cancer	3.33e-06	4.1e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—ITPR1—breast cancer	3.33e-06	4.09e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—HPGDS—breast cancer	3.32e-06	4.08e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—HBA1—breast cancer	3.3e-06	4.06e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—MYC—breast cancer	3.27e-06	4.02e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—TGFB1—breast cancer	3.26e-06	4.01e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—CXCL8—breast cancer	3.24e-06	3.99e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—ABCB1—breast cancer	3.23e-06	3.97e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—HRAS—breast cancer	3.22e-06	3.96e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—GSTT1—breast cancer	3.22e-06	3.96e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—ACHE—breast cancer	3.22e-06	3.96e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—ABCB1—breast cancer	3.2e-06	3.94e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—SRC—breast cancer	3.2e-06	3.93e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—EGFR—breast cancer	3.2e-06	3.93e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—TYMS—breast cancer	3.17e-06	3.9e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—CDKN1B—breast cancer	3.17e-06	3.89e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—TYMS—breast cancer	3.14e-06	3.87e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—GSTM1—breast cancer	3.13e-06	3.86e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—PLA2G4A—breast cancer	3.13e-06	3.86e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—NCOR1—breast cancer	3.13e-06	3.86e-05	CbGpPWpGaD
Hydromorphone—OPRM1—GPCR downstream signaling—AKT1—breast cancer	3.13e-06	3.85e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—VEGFA—breast cancer	3.11e-06	3.83e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—NCOR1—breast cancer	3.11e-06	3.82e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—GSTM1—breast cancer	3.11e-06	3.82e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—PLA2G4A—breast cancer	3.11e-06	3.82e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—CASP3—breast cancer	3.1e-06	3.82e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—IL2—breast cancer	3.1e-06	3.81e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—STAT3—breast cancer	3.08e-06	3.79e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—IL6—breast cancer	3.08e-06	3.79e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—CYP17A1—breast cancer	3.04e-06	3.75e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—KRAS—breast cancer	3.02e-06	3.72e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—CCND1—breast cancer	3.02e-06	3.72e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—ENO1—breast cancer	3.01e-06	3.71e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—PTGS1—breast cancer	3.01e-06	3.71e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—JUN—breast cancer	3.01e-06	3.71e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—GPX1—breast cancer	3e-06	3.69e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—CTNNB1—breast cancer	2.99e-06	3.68e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—GPX1—breast cancer	2.98e-06	3.66e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—CYP1A1—breast cancer	2.97e-06	3.66e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—CYP2D6—breast cancer	2.96e-06	3.64e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—ERCC2—breast cancer	2.95e-06	3.63e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—MAPK3—breast cancer	2.95e-06	3.63e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—CYP1A1—breast cancer	2.95e-06	3.62e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—MMP9—breast cancer	2.93e-06	3.61e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—ERCC2—breast cancer	2.92e-06	3.59e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—CDKN1A—breast cancer	2.92e-06	3.59e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—PTEN—breast cancer	2.91e-06	3.59e-05	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—PTEN—breast cancer	2.91e-06	3.58e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—NCOA2—breast cancer	2.9e-06	3.57e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—MYC—breast cancer	2.87e-06	3.53e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—TGFB1—breast cancer	2.86e-06	3.52e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—MAPK8—breast cancer	2.85e-06	3.51e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—AKT1—breast cancer	2.84e-06	3.5e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—FASN—breast cancer	2.81e-06	3.46e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—EGFR—breast cancer	2.8e-06	3.45e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—BCHE—breast cancer	2.8e-06	3.45e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—PIK3CA—breast cancer	2.77e-06	3.41e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—MTHFR—breast cancer	2.77e-06	3.41e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—SLC5A5—breast cancer	2.77e-06	3.41e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—MTHFR—breast cancer	2.75e-06	3.38e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—SRC—breast cancer	2.7e-06	3.33e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—TP53—breast cancer	2.68e-06	3.3e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—SLC2A1—breast cancer	2.67e-06	3.29e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—NQO1—breast cancer	2.67e-06	3.29e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—KRAS—breast cancer	2.65e-06	3.26e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—VEGFA—breast cancer	2.63e-06	3.24e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—STAT3—breast cancer	2.61e-06	3.21e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—HRAS—breast cancer	2.57e-06	3.16e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—CYP1B1—breast cancer	2.56e-06	3.15e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—CAV1—breast cancer	2.55e-06	3.14e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—CAV1—breast cancer	2.53e-06	3.12e-05	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—PIK3CA—breast cancer	2.51e-06	3.09e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—HSP90AA1—breast cancer	2.51e-06	3.09e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—MAPK3—breast cancer	2.49e-06	3.06e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—IL6—breast cancer	2.46e-06	3.02e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—NCOA1—breast cancer	2.45e-06	3.01e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—PIK3CA—breast cancer	2.43e-06	2.99e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—MYC—breast cancer	2.42e-06	2.98e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	2.42e-06	2.98e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—TGFB1—breast cancer	2.42e-06	2.97e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—STK11—breast cancer	2.41e-06	2.96e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—CYP19A1—breast cancer	2.41e-06	2.96e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—EGFR—breast cancer	2.37e-06	2.91e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—TP53—breast cancer	2.35e-06	2.9e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—PIK3CG—breast cancer	2.33e-06	2.86e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—PIK3CG—breast cancer	2.31e-06	2.84e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—AKT1—breast cancer	2.27e-06	2.79e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—HRAS—breast cancer	2.25e-06	2.77e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—COMT—breast cancer	2.24e-06	2.76e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—KRAS—breast cancer	2.24e-06	2.75e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—GSTP1—breast cancer	2.23e-06	2.74e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—HMOX1—breast cancer	2.2e-06	2.71e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—ITPR1—breast cancer	2.19e-06	2.7e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—IL6—breast cancer	2.15e-06	2.65e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—ABCB1—breast cancer	2.11e-06	2.6e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—TYMS—breast cancer	2.07e-06	2.55e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—PIK3CA—breast cancer	2.06e-06	2.53e-05	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—AKT1—breast cancer	2.05e-06	2.53e-05	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—PIK3CA—breast cancer	2.05e-06	2.52e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—GSTM1—breast cancer	2.05e-06	2.52e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—NCOR1—breast cancer	2.05e-06	2.52e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—PLA2G4A—breast cancer	2.05e-06	2.52e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—PIK3CD—breast cancer	2.05e-06	2.52e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—PIK3CD—breast cancer	2.03e-06	2.5e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—ALB—breast cancer	2.02e-06	2.48e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—ALB—breast cancer	2e-06	2.46e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—TP53—breast cancer	1.99e-06	2.45e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—AKT1—breast cancer	1.99e-06	2.45e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—GPX1—breast cancer	1.96e-06	2.41e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—CYP1A1—breast cancer	1.94e-06	2.39e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—NOS3—breast cancer	1.93e-06	2.38e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—ERCC2—breast cancer	1.93e-06	2.37e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—NOS3—breast cancer	1.91e-06	2.36e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—HRAS—breast cancer	1.9e-06	2.34e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—IL6—breast cancer	1.82e-06	2.24e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—MTHFR—breast cancer	1.81e-06	2.23e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—PIK3CB—breast cancer	1.78e-06	2.19e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—PIK3CB—breast cancer	1.77e-06	2.17e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—PTGS2—breast cancer	1.77e-06	2.17e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—PTGS2—breast cancer	1.75e-06	2.16e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—AKT1—breast cancer	1.68e-06	2.07e-05	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—AKT1—breast cancer	1.67e-06	2.06e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—CAV1—breast cancer	1.67e-06	2.06e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—PTEN—breast cancer	1.54e-06	1.9e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—PTEN—breast cancer	1.53e-06	1.88e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—PIK3CG—breast cancer	1.52e-06	1.87e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—PIK3CD—breast cancer	1.34e-06	1.65e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—ALB—breast cancer	1.32e-06	1.62e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—NOS3—breast cancer	1.26e-06	1.55e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—PIK3CB—breast cancer	1.17e-06	1.43e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—PTGS2—breast cancer	1.16e-06	1.42e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—PIK3CA—breast cancer	1.09e-06	1.34e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—PIK3CA—breast cancer	1.08e-06	1.33e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—PTEN—breast cancer	1.01e-06	1.24e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—AKT1—breast cancer	8.88e-07	1.09e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—AKT1—breast cancer	8.8e-07	1.08e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—PIK3CA—breast cancer	7.11e-07	8.74e-06	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—AKT1—breast cancer	5.81e-07	7.14e-06	CbGpPWpGaD
